Impact of strain heterogeneity on Lyme disease serology in Europe:: Comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato

被引:48
作者
Hauser, U
Krahl, H
Peters, H
Fingerle, V
Wilske, B
机构
[1] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Mikrobiol, D-80336 Munich, Germany
[2] Behring Diagnost GMBH, D-35001 Marburg, Germany
关键词
D O I
10.1128/JCM.36.2.427-436.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
For the standardization of serological tests for Lyme borreliosis (LB) in Europe, the influence of the heterogeneity of Borrelia burgdorferi sensu late must be assessed in detail. For this study four immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assays (ELISAs) with octyl-P-D-glucopyranoside extracts of strains PK0 (Borrelia afzelii), PBi (Borrelia garinii), and PKa2 and B31 (both B. burgdorferi sensu stricto) were compared. Strains PK0, PBi, and PKa2 at the passages used for antigen preparations abundantly expressed outer surface protein C (OspC), whereas strain B31 at the passage used for antigen preparation did not express OspC. Sera (all from Germany) from 222 patients with clinically defined LB of ail stages, 133 blood donors, and 458 forest workers were tested. None of the forest workers had symptoms consistent with LB at the time that the samples were collected. For IgM tests, receiver operating characteristic curves demonstrated that discrimination between sera from patients end blood donors was best with strain PK0 and worst with strain B31. The discriminatory abilities of the four IgG ELISAs were similar in a diagnostically reasonable specificity range (90 to 100%). More than 20% of the sera from forest workers reacted strongly in the PK0 IgG ELISA (optical density value, >1.5; other assays, less than 8%). Western blots of the sera with the most discrepant ELISA results revealed almost exclusive reactivity with p17. This highly immunogenic antigen is only expressed by strain PK0. This observation might be important for the development of assays enabling discrimination between asymptomatic or previous infection and active disease.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 49 条
[21]   ELECTROBLOTTING OF MULTIPLE GELS - A SIMPLE APPARATUS WITHOUT BUFFER TANK FOR RAPID TRANSFER OF PROTEINS FROM POLYACRYLAMIDE TO NITROCELLULOSE [J].
KYHSEANDERSEN, J .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1984, 10 (3-4) :203-209
[22]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[23]   COMPARISON OF DIFFERENT STRAINS OF BORRELIA-BURGDORFERI SENSU LATO USED AS ANTIGENS IN ENZYME-LINKED IMMUNOSORBENT ASSAYS [J].
MAGNARELLI, LA ;
ANDERSON, JF ;
JOHNSON, RC ;
NADELMAN, RB ;
WORMSER, GP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1154-1158
[24]   Analysis of the human antibody response to outer surface protein C (OspC) of Borrelia burgdorferi sensu stricto, B-garinii, and B-afzelii [J].
Mathiesen, MJ ;
Hansen, K ;
Axelsen, N ;
HalkierSorensen, L ;
Theisen, M .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1996, 185 (03) :121-129
[25]  
MUNCHHOFF P, 1987, ZBL BAKT-INT J MED M, V263, P412
[26]   Serodiagnosis of lyme borreliosis by Borrelia burgdorferi sensu stricto, B-garinii, and B-afzelii Western Blots (immunoblots) [J].
Norman, GL ;
Antig, JM ;
Bigaignon, G ;
Hogrefe, WR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1732-1738
[27]  
PETERS H, 1993, LAB MED, V16, P248
[28]  
PREACMURSIC V, 1986, ZBL BAKT-INT J MED M, V263, P112
[29]   MOLECULAR AND IMMUNOLOGICAL CHARACTERIZATION OF THE P83/100 PROTEIN OF VARIOUS BORRELIA-BURGDORFERI SENSU-LATO STRAINS [J].
ROSSLER, D ;
EIFFERT, H ;
JAURISHEIPKE, S ;
LEHNERT, G ;
PREACMURSIC, V ;
TEEPE, J ;
SCHLOTT, T ;
SOUTSCHEK, E ;
WILSKE, B .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1995, 184 (01) :23-32
[30]   DISTRIBUTION AND MOLECULAR ANALYSIS OF LYME-DISEASE SPIROCHETES, BORRELIA-BURGDORFERI, ISOLATED FROM TICKS THROUGHOUT CALIFORNIA [J].
SCHWAN, TG ;
SCHRUMPF, ME ;
KARSTENS, RH ;
CLOVER, JR ;
WONG, J ;
DAUGHERTY, M ;
STRUTHERS, M ;
ROSA, PA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (12) :3096-3108